Back
CI Bio-Revolution Idx ETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
55
CDNA.TO
CI Bio-Revolution Idx ETF
Last Price:
17.73
Seasonality Move:
-8.88%
Buy
65
RYTM
Rhythm Pharmaceuticals
Last Price:
45.37
Seasonality Move:
4.7%
Buy
55
CI Bio-Revolution Idx ETF (CDNA.TO)
is a Buy
Is CI Bio-Revolution Idx ETF a Buy, Sell or Hold?
- The current CI Bio-Revolution Idx ETF [CDNA.TO] share price is $17.73. The Score for CDNA.TO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CDNA.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $45.61. The Score for RYTM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CDNA.TO Stock Price Chart
What is CI Bio-Revolution Idx ETF's stock price today?
-
The CI Bio-Revolution Idx ETF share price today is $17.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDNA.TO is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $45.61
The current trend is moderately bearish and RYTM is experiencing slight selling pressure.
CDNA.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 94.34 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.54 - 17.8) | Buy |
| Bollinger Bands (100): | (15.69 - 17.39) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 48.36 | Sell |
| Chaikin Money Flow: | -148321 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.88 - 49.4) | Sell |
| Bollinger Bands (100): | (38.35 - 46.45) | Buy |
CDNA.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.73 | Sell |
| 20-day SMA: | 17.71 | Buy |
| 50-day SMA: | 17 | Buy |
| 200-day SMA: | 16.67 | Buy |
| 8-day EMA: | 17.73 | Buy |
| 20-day EMA: | 17.61 | Buy |
| 50-day EMA: | 17.19 | Buy |
| 200-day EMA: | 16.91 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.89 | Sell |
| 20-day SMA: | 46.4 | Sell |
| 50-day SMA: | 45.28 | Buy |
| 200-day SMA: | 41.63 | Buy |
| 8-day EMA: | 46.02 | Sell |
| 20-day EMA: | 46.15 | Sell |
| 50-day EMA: | 45.13 | Buy |
| 200-day EMA: | 39.96 | Buy |
CI Bio-Revolution Idx ETF Earnings Growth & CDNA.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.24 per share, a decrease this year of $1.32 per share, and an increase next year of $1.68 per share.
CI Bio-Revolution Idx ETF Technical Analysis
| Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Aug 7 | Aug 8 | Aug 9 | Aug 12 | Aug 13 | Aug 14 | Aug 15 | Aug 16 | Aug 19 | Aug 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||